1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children’s Hospital of Richmond at VCU, Richmond, VA.
2Division of Hematology/Oncology, Simmons Cancer Institute at SIU School of Medicine, Springfield, IL.
3Department of Pathology, Johns Hopkins University, Baltimore, MD.
4Adult and Pediatric ECLS, INOVA Fairfax Hospital, Falls Church, VA.
5Division of Pediatric Critical Care Medicine, Department of Pediatrics, Weill Cornell Medicine, New York, NY.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
The Collaborative Pediatric Critical Care Research Network was funded by the National Institute of Child Health and Human Development.
Dr. Dalton disclosed off-label product use of extracorporeal membrane oxygenation (ECMO), and she received funding from Innovative ECMO Concepts. The remaining authors have disclosed that they do not have any potential conflicts of interest.
This article was prepared using the Bleeding and Thrombosis During ECMO (BATE) Study Data Set obtained from the Collaborative Pediatric Critical Care Research Network Data Coordinating Center, and it does not necessarily reflect the opinions or views of the BATE investigators or the National Institute of Child Health and Human Development.
For information regarding this article, E-mail: [email protected]